Schedule II - Condensed Financial Information of Registrant - Statement of Cash Flows (Details) - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Cash Flows from Operating Activities
Net income (loss) from continuing operations	$ (18,438,000)	$ (34,240,000)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	255,000	1,671,000
Accretion of Series B Preferred Stock	804,000	0
Deferred income tax expense	0	0
Change in fair value of contingent considerations	(6,220,000)	(146,000)
Other gains/losses	0	(500,000)
Changes in operating assets and liabilities:
Other assets	508,000	2,135,000
Net cash provided by (used in) operating activities - discontinued operations	0	3,195,000
Cash Flows From Investing Activities
Purchases of investments	(301,149,000)	(193,590,000)
Cash Flows From Financing Activities
Issuance of stock warrants	1,924,000	0
Paydown of long-term debt	0	(14,250,000)
Dividends paid on Series A Preferred Stock	0	(439,000)
Redemption premium on Series A Preferred Stock	0	(397,000)
Net cash provided by (used in) financing activities	15,500,000	(21,086,000)
Net increase (decrease) in cash	(292,000)	16,529,000
Cash at beginning of period	27,654,000	11,125,000
Cash at end of period	27,362,000	27,654,000
Supplemental Disclosure of Cash Flow Information:
Interest paid	2,351,000	4,260,000
Senior Secured Notes Call Premium	0	753,000
Series B Preferred Stock
Cash Flows From Financing Activities
Issuance of Preferred Stock	5,576,000	0
Series C Preferred Stock
Cash Flows From Financing Activities
Issuance of Preferred Stock	8,000,000	0
CIS
Cash Flows From Investing Activities
Proceeds from contingent consideration in CIS sale	10,000,000	0
Proceeds from sale of renewal rights/agency business	0	51,778,000
Parent Company
Cash Flows from Operating Activities
Net income (loss) from continuing operations	(18,438,000)	(30,900,000)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	255,000	1,671,000
Accretion of Series B Preferred Stock	804,000	0
Equity in undistributed (income) loss of subsidiaries	13,392,000	11,692,000
Stock-based compensation expense	56,000	78,000
Deferred income tax expense	(140,000)	4,731,000
Change in fair value of contingent considerations	(6,220,000)	(146,000)
Other gains/losses	0	(500,000)
Changes in operating assets and liabilities:
Due from subsidiaries	(224,000)	(3,088,000)
Due from Affiliate	0	33,000
Current income tax recoverable	0	0
Other assets	70,000	1,055,000
Other liabilities	1,684,000	(2,080,000)
Net cash provided by (used in) operating activities - discontinued operations	0	(3,527)
Net cash provided by operating activities	(8,761,000)	(20,981,000)
Cash Flows From Investing Activities
Contributions to subsidiaries	(20,899,000)	(14,400,000)
Return of capital from subsidiaries	4,000,000	0
Dividends received from subsidiaries	0	8,257,000
Disposal of Fixed Assets, net	0	74,000
Net cash provided by (used in) investing activities	(6,899,000)	45,709,000
Cash Flows From Financing Activities
Issuance of stock warrants	1,924,000	0
Repayment of Series A Preferred Stock	0	(6,000,000)
Paydown of long-term debt	0	(14,250,000)
Dividends paid on Series A Preferred Stock	0	(439,000)
Redemption premium on Series A Preferred Stock	0	(397,000)
Net cash provided by (used in) financing activities	15,500,000	(21,086,000)
Net increase (decrease) in cash	(160,000)	3,642,000
Cash at beginning of period	6,816,000	3,174,000
Cash at end of period	6,656,000	6,816,000
Supplemental Disclosure of Cash Flow Information:
Interest paid	2,739,000	4,649,000
PHI Capital Contribution of WPIC to TIC	7,587,000	0
Senior Secured Notes Call Premium	0	753,000
Parent Company | Series B Preferred Stock
Cash Flows From Financing Activities
Issuance of Preferred Stock	5,576,000	0
Parent Company | Series C Preferred Stock
Cash Flows From Financing Activities
Issuance of Preferred Stock	8,000,000	0
Parent Company | CIS
Cash Flows From Investing Activities
Proceeds from contingent consideration in CIS sale	10,000,000	0
Proceeds from sale of renewal rights/agency business	$ 0	$ 51,778,000